Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03744715
Title A Study to Allow Continued Treatment of Patients Who Have Participated in a Spectrum-Sponsored Poziotinib Study
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Pacific Shores Medical Group Long Beach California 90813 United States Details
Hattiesburg Clinic Hematology Oncology Hattiesburg Mississippi 39401 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016 United States Details
UPMC Pittsburgh Pennsylvania 15232 United States Details
UT MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field